Crispr Therapeutics shares owned by Steel Peak Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Steel Peak Wealth Management
from 13F filings
Historical chart of Steel Peak Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Steel Peak Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Steel Peak Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $699k | 10k | 68.16 |
| 2023-12-31 | $280k | 4.5k | 62.60 |
| 2023-09-30 | $262k | 5.8k | 45.39 |
| 2023-06-30 | $283k | 5.0k | 56.14 |
| 2023-03-31 | $426k | 9.4k | 45.23 |
| 2022-12-31 | $272k | 6.7k | 40.65 |
| 2022-09-30 | $390k | 6.0k | 65.28 |
| 2022-06-30 | $443k | 7.3k | 60.78 |
| 2022-03-31 | $867k | 14k | 62.81 |
| 2021-12-31 | $890k | 12k | 75.76 |
| 2021-09-30 | $701k | 6.3k | 112.00 |
| 2021-06-30 | $602k | 3.7k | 162.00 |
| 2021-03-31 | $318k | 2.6k | 121.79 |
More positions owned by Steel Peak Wealth Management
View all positions for Steel Peak Wealth Management